PrecisioBiotix Therapeutics
PrivateLast Round
Grant
Jun 16, 2025
Total Funding Raised
$1.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PrecisioBiotix Therapeutics operates in Healthcare & Life Sciences and is based in Dover, Delaware. Its latest recorded funding round was a Grant round in June 2025.
PrecisioBiotix Therapeutics is a biotechnology company that develops precision antibacterial biological solutions, including lysin, phage, and amurin products, to combat antibiotic-resistant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrecisioBiotix Therapeutics Comparables
Compare PrecisioBiotix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Locus Biosciences | 82% | |
| Micreos | 82% | |
| BioNTech SE | 78% |
For institutional investors. Book with your work email.
PrecisioBiotix Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
PrecisioBiotix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 37% MoM.
- Aug 1, 2026
Grew 38% QoQ, from 8 to 11 employees.
For institutional investors. Book with your work email.
PrecisioBiotix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PrecisioBiotix Therapeutics's valuation, stock price, and market status.
Is PrecisioBiotix Therapeutics a public or private company?
PrecisioBiotix Therapeutics is a private company.
What is the current stock price of PrecisioBiotix Therapeutics?
PrecisioBiotix Therapeutics is a private company, so its shares have no public market price. Caplight tracks PrecisioBiotix Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PrecisioBiotix Therapeutics worth (valuation)?
Valuation information for PrecisioBiotix Therapeutics is not publicly available.
Can I buy PrecisioBiotix Therapeutics stock?
PrecisioBiotix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PrecisioBiotix Therapeutics's last funding round?
PrecisioBiotix Therapeutics's most recent funding round was Grant on June 16, 2025.
Who are the main investors in PrecisioBiotix Therapeutics?
Key investors in PrecisioBiotix Therapeutics include Bill & Melinda Gates Foundation.
Will PrecisioBiotix Therapeutics IPO soon?
No public IPO plans have been announced for PrecisioBiotix Therapeutics.
How can I track PrecisioBiotix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PrecisioBiotix Therapeutics's shares on secondary markets.